News

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...
Humanized murine anti-TNF mAb (infliximab) and a soluble TNF receptor linked to human IgG1 (etanercept) have been developed and have been evaluated for asthma treatment. [74] GM Walsh has no ...
Ariana Boyle, 7, has been hospitalised her more than 50 times due to her severe brittle asthma - but a last-resort treatment ...
The World Health Organization (WHO) estimates that asthma affects over 260 million people globally, contributing to around ...
Biologics are made using parts of living ... Nucala is used with other asthma medications to treat eosinophilic asthma and help prevent asthma attacks. Nucala is prescribed for chronic ...
A recent policy change by the largest private insurer in New Mexico could result in patients with severe asthma facing more ...
SAN DIEGO — Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and 2023, according to a poster presented here. “That seems ...
During National Asthma and Allergy Awareness Month, the high prevalence and costs of allergies and asthma in the US are ...
Asthma is a chronic condition which leads to the airways to constrict and makes breathing difficult. Asthma has no cure, although medication can help manage symptoms. Asthma can be diagnosed and ...
All belong to a class of drugs known as biologics. The decision is expected to affect thousands of patients. It’s estimated that between 5% and 10% of asthma patients have severe asthma ...
Biologic treatment costs for plaque psoriasis more than doubled from 2007 to 2021, despite cheaper alternatives. Switching to the lowest-cost biologic in each class could reduce treatment costs by ...